MAVUPHARMA INC has a total of 24 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), China and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are PHOTOCHEMICAL CO LTD, SHANGHAI ACEBRIGHT PHARMACEUTICALS CO LTD and ADAMED PHARMA S A.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | China | 3 | |
#3 | United States | 3 | |
#4 | Brazil | 2 | |
#5 | Canada | 2 | |
#6 | Israel | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Mexico | 2 | |
#9 | Argentina | 1 | |
#10 | EPO (European Patent Office) | 1 | |
#11 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Heterocyclic compounds | |
#6 | Special acyclic compounds | |
#7 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Gallatin William Michael | 17 |
#2 | Dietsch Gregory N | 17 |
#3 | Odingo Joshua | 7 |
#4 | Florio Vincent | 7 |
#5 | Venkateshappa Chandregowda | 4 |
#6 | Duraiswamy Athisayamani Jeyaraj | 4 |
#7 | William Michael Gallatin | 4 |
#8 | Gregory N Dietsch | 4 |
#9 | Gallatin William | 1 |
#10 | Dietsch Gregory | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019177971A1 | Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereof | |
US2019282703A1 | Ectonucleotide pyrophosphatase-phosphodiesterase (enpp) conjugates and uses thereof | |
KR20190126283A | Phosphodiesterase Inhibitors and Microbial Treatment Methods | |
US2020085782A1 | Compositions and methods of enhancing or augmenting type i ifn production |